291 related articles for article (PubMed ID: 17826792)
21. Chemical profiling of HIV-1 capsid-targeting antiviral PF74.
Wang L; Casey MC; Vernekar SKV; Do HT; Sahani RL; Kirby KA; Du H; Hachiya A; Zhang H; Tedbury PR; Xie J; Sarafianos SG; Wang Z
Eur J Med Chem; 2020 Aug; 200():112427. PubMed ID: 32438252
[TBL] [Abstract][Full Text] [Related]
22. HIV-1 maturation inhibitor bevirimat stabilizes the immature Gag lattice.
Keller PW; Adamson CS; Heymann JB; Freed EO; Steven AC
J Virol; 2011 Feb; 85(4):1420-8. PubMed ID: 21106735
[TBL] [Abstract][Full Text] [Related]
23. Rationally designed interfacial peptides are efficient in vitro inhibitors of HIV-1 capsid assembly with antiviral activity.
Bocanegra R; Nevot M; Doménech R; López I; Abián O; Rodríguez-Huete A; Cavasotto CN; Velázquez-Campoy A; Gómez J; Martínez MÁ; Neira JL; Mateu MG
PLoS One; 2011; 6(9):e23877. PubMed ID: 21931621
[TBL] [Abstract][Full Text] [Related]
24. Structural and functional insights into the HIV-1 maturation inhibitor binding pocket.
Waki K; Durell SR; Soheilian F; Nagashima K; Butler SL; Freed EO
PLoS Pathog; 2012; 8(11):e1002997. PubMed ID: 23144615
[TBL] [Abstract][Full Text] [Related]
25. Structure of a monomeric mutant of the HIV-1 capsid protein.
Shin R; Tzou YM; Krishna NR
Biochemistry; 2011 Nov; 50(44):9457-67. PubMed ID: 21995733
[TBL] [Abstract][Full Text] [Related]
26. Design, synthesis and structure-activity relationships of 4-phenyl-1H-1,2,3-triazole phenylalanine derivatives as novel HIV-1 capsid inhibitors with promising antiviral activities.
Sun L; Huang T; Dick A; Meuser ME; Zalloum WA; Chen CH; Ding X; Gao P; Cocklin S; Lee KH; Zhan P; Liu X
Eur J Med Chem; 2020 Mar; 190():112085. PubMed ID: 32066010
[TBL] [Abstract][Full Text] [Related]
27. Ebselen, a Small-Molecule Capsid Inhibitor of HIV-1 Replication.
Thenin-Houssier S; de Vera IM; Pedro-Rosa L; Brady A; Richard A; Konnick B; Opp S; Buffone C; Fuhrmann J; Kota S; Billack B; Pietka-Ottlik M; Tellinghuisen T; Choe H; Spicer T; Scampavia L; Diaz-Griffero F; Kojetin DJ; Valente ST
Antimicrob Agents Chemother; 2016 Apr; 60(4):2195-208. PubMed ID: 26810656
[TBL] [Abstract][Full Text] [Related]
28. Capsid (CA) protein as a novel drug target: recent progress in the research of HIV-1 CA inhibitors.
Zhang J; Liu X; De Clercq E
Mini Rev Med Chem; 2009 Apr; 9(4):510-8. PubMed ID: 19356128
[TBL] [Abstract][Full Text] [Related]
29. PF74 and Its Novel Derivatives Stabilize Hexameric Lattice of HIV-1 Mature-Like Particles.
Dostálková A; Škach K; Kaufman F; Křížová I; Hadravová R; Flegel M; Ruml T; Hrabal R; Rumlová M
Molecules; 2020 Apr; 25(8):. PubMed ID: 32325987
[TBL] [Abstract][Full Text] [Related]
30. Application of an NMR/Crystallography Fragment Screening Platform for the Assessment and Rapid Discovery of New HIV-CA Binding Fragments.
Lang S; Fletcher DA; Petit AP; Luise N; Fyfe P; Zuccotto F; Porter D; Hope A; Bellany F; Kerr C; Mackenzie CJ; Wyatt PG; Gray DW
ChemMedChem; 2024 Jul; 19(13):e202400025. PubMed ID: 38581280
[TBL] [Abstract][Full Text] [Related]
31. 1H, 15N and 13C assignments of the dimeric C-terminal domain of HIV-1 capsid protein.
Jung J; Byeon IJ; Ahn J; Concel J; Gronenborn AM
Biomol NMR Assign; 2010 Apr; 4(1):21-3. PubMed ID: 19921549
[TBL] [Abstract][Full Text] [Related]
32. Alkyl Amine Bevirimat Derivatives Are Potent and Broadly Active HIV-1 Maturation Inhibitors.
Urano E; Ablan SD; Mandt R; Pauly GT; Sigano DM; Schneider JP; Martin DE; Nitz TJ; Wild CT; Freed EO
Antimicrob Agents Chemother; 2016 Jan; 60(1):190-7. PubMed ID: 26482309
[TBL] [Abstract][Full Text] [Related]
33. Allosteric Regulation of HIV-1 Capsid Structure for Gag Assembly, Virion Production, and Viral Infectivity by a Disordered Interdomain Linker.
Koma T; Kotani O; Miyakawa K; Ryo A; Yokoyama M; Doi N; Adachi A; Sato H; Nomaguchi M
J Virol; 2019 Sep; 93(17):. PubMed ID: 31189701
[TBL] [Abstract][Full Text] [Related]
34. HIV capsid is a tractable target for small molecule therapeutic intervention.
Blair WS; Pickford C; Irving SL; Brown DG; Anderson M; Bazin R; Cao J; Ciaramella G; Isaacson J; Jackson L; Hunt R; Kjerrstrom A; Nieman JA; Patick AK; Perros M; Scott AD; Whitby K; Wu H; Butler SL
PLoS Pathog; 2010 Dec; 6(12):e1001220. PubMed ID: 21170360
[TBL] [Abstract][Full Text] [Related]
35. Helical structure determined by NMR of the HIV-1 (345-392)Gag sequence, surrounding p2: implications for particle assembly and RNA packaging.
Morellet N; Druillennec S; Lenoir C; Bouaziz S; Roques BP
Protein Sci; 2005 Feb; 14(2):375-86. PubMed ID: 15659370
[TBL] [Abstract][Full Text] [Related]
36. Structure of the N-terminal 283-residue fragment of the immature HIV-1 Gag polyprotein.
Tang C; Ndassa Y; Summers MF
Nat Struct Biol; 2002 Jul; 9(7):537-43. PubMed ID: 12032547
[TBL] [Abstract][Full Text] [Related]
37. The structural biology of HIV assembly.
Ganser-Pornillos BK; Yeager M; Sundquist WI
Curr Opin Struct Biol; 2008 Apr; 18(2):203-17. PubMed ID: 18406133
[TBL] [Abstract][Full Text] [Related]
38. The HIV-1 capsid protein as a drug target: recent advances and future prospects.
Domenech R; Neira JL
Curr Protein Pept Sci; 2013 Dec; 14(8):658-68. PubMed ID: 24106962
[TBL] [Abstract][Full Text] [Related]
39. Cryo-electron microscopy of tubular arrays of HIV-1 Gag resolves structures essential for immature virus assembly.
Bharat TA; Castillo Menendez LR; Hagen WJ; Lux V; Igonet S; Schorb M; Schur FK; Kräusslich HG; Briggs JA
Proc Natl Acad Sci U S A; 2014 Jun; 111(22):8233-8. PubMed ID: 24843179
[TBL] [Abstract][Full Text] [Related]
40. Specific Inhibitors of HIV Capsid Assembly Binding to the C-Terminal Domain of the Capsid Protein: Evaluation of 2-Arylquinazolines as Potential Antiviral Compounds.
Machara A; Lux V; Kožíšek M; Grantz Šašková K; Štěpánek O; Kotora M; Parkan K; Pávová M; Glass B; Sehr P; Lewis J; Müller B; Kräusslich HG; Konvalinka J
J Med Chem; 2016 Jan; 59(2):545-58. PubMed ID: 26685880
[TBL] [Abstract][Full Text] [Related]
[Previous] [Next] [New Search]
